Get the Stockscreener App
29.41
1.08%
-0.32
After Hours:
29.41
Phibro Animal Health Corp stock is traded at $29.41, with a volume of 353.03K.
It is down -1.08% in the last 24 hours and up +22.75% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$29.73
Open:
$29.9
24h Volume:
353.03K
Relative Volume:
1.30
Market Cap:
$599.01M
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
79.49
EPS:
0.37
Net Cash Flow:
$37.02M
1W Performance:
-4.51%
1M Performance:
+22.75%
6M Performance:
+41.26%
1Y Performance:
+56.19%
1-Day Range:
$29.19
$30.07
1-Week Range:
$29.19
$31.71
52-Week Range:
$16.16
$31.80
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
29.41 | 1.25B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
148.60 | 68.99B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.43 | 46.36B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.60 | 44.74B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.06 | 18.81B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.01 | 13.33B | 2.99B | 1.21B | 1.13B | 25.06 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Principal Financial Group Inc. Has $2.17 Million Holdings in Phibro Animal Health Corporation (NASDAQ:PAHC) - Defense World
What analysts say about Phibro Animal Health Corporation stockDouble-digit growth - Jammu Links News
Phibro Animal Health Corporation (NASDAQ:PAHC) Stock Holdings Trimmed by Teacher Retirement System of Texas - Defense World
Elevance Health Q2 Earnings Miss Estimates on Rising Medical Costs - TradingView
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC) - Yahoo Finance
Why Phibro Animal Health Corporation stock attracts strong analyst attentionCapital Preservation Investment Ideas - Newser
Best Growth Stocks to Buy for July 15th - The Globe and Mail
Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock - Yahoo Finance
Phibro Animal Health (PAHC) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Phibro Animal Health stock reaches 52-week high at $30.60 By Investing.com - Investing.com South Africa
Phibro Animal Health stock reaches 52-week high at $30.60 - Investing.com India
Phibro (PAHC) Soars 6.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Upgraded by JPMorgan Chase & Co. to Overweight Rating - Defense World
Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost - Benzinga
Phibro Animal Health (PAHC) Rises on J.P. Morgan Upgrade - GuruFocus
Phibro Animal Health shares surge on J.P. Morgan upgrade - grafa.com
Phibro Animal Health stock surges after JPMorgan upgrade to Overweight By Investing.com - Investing.com Nigeria
Phibro Animal Health stock surges after JPMorgan upgrade to Overweight - Investing.com Australia
Phibro rises after J.P. Morgan upgrades to 'overweight' - TradingView
U.S. Bancorp To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday - NewsBreak: Local News & Alerts
Phibro Animal Health (PAHC) Receives Upgrade and Price Target Bo - GuruFocus
This Constellation Brands Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday - Benzinga
Phibro Animal Health upgraded to Overweight from Neutral at JPMorgan - TipRanks
Analog Devices, Constellation Brands, Phibro Animal Health - TradingView
JPMorgan upgrades Phibro Animal Health stock rating to Overweight on strong results - Investing.com
Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Phibro Animal Health stock hits 52-week high at 26.58 USD - Investing.com
Phibro Animal Health Corporation(NasdaqGM:PAHC) dropped from Russell 3000E Value Index - MarketScreener
Phibro Animal Health price target raised to $26 from $21 at Morgan Stanley - TipRanks
Best Growth Stocks to Buy for June 25th - yahoo.co
Phibro Animal Health (NASDAQ:PAHC) Upgraded at BNP Paribas - Defense World
Reasons to Add PAHC Stock to Your Portfolio Right Now - Yahoo Finance
GAMMA Investing LLC Has $784,000 Stock Position in Phibro Animal Health Corporation (NASDAQ:PAHC) - Defense World
Phibro Animal Health (NASDAQ:PAHC) Upgraded to “Neutral” at BNP Paribas Exane - Defense World
Zacks.com featured highlights include Popular, Affiliated Managers, Astronics and Phibro Animal Health - The Globe and Mail
Phibro Animal Health upgraded to Neutral from Underperform at BNP Paribas Exane - TipRanks
Phibro Animal Health (PAHC) Rating Upgraded by Analyst | PAHC Stock News - GuruFocus
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Bank of America Corp DE Cuts Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 16,917 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Zacks.com featured highlights Urban Outfitters, Phibro Animal Health and Strattec Security - Yahoo Finance
3 Stocks Showing Positive Momentum Despite Trade Tensions - Yahoo Finance
Cetera Investment Advisers Takes $204,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Jane Street Group LLC Trims Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Deutsche Bank AG Boosts Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Ameriprise Financial Inc. Purchases 21,576 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Millennium Management LLC Has $4.36 Million Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro at Stifel Jaws & Paws Conference: Strategic Growth and Challenges - Investing.com India
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):